Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CapsoVision (CV) Liabilities and Shareholders Equity (2024 - 2025)

CapsoVision's Liabilities and Shareholders Equity history spans 2 years, with the latest figure at $18.2 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 8.1% to $18.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $70.2 million, a N/A change, with the full-year FY2025 number at $18.2 million, up 8.1% from a year prior.
  • Liabilities and Shareholders Equity hit $18.2 million in Q4 2025 for CapsoVision, down from $25.7 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for CV hit a ceiling of $25.7 million in Q3 2025 and a floor of $9.5 million in Q2 2025.